ArticleJournal of neurology2026
Postictal aggression in epilepsy: prevalence, clinical correlates, and psychosocial impact.
Article in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePostictal aggression (PIA) is an under-researched phenomenon with potentially harmful consequences for patients and their environment. This study assessed the prevalence of PIA, its associated clinical variables, and its relationship with quality of life (QoL), anxiety, and depression.
methodsIn this cross-sectional study, consecutive patients with epilepsy (≥ 1 seizure in the past 12 months; age ≥ 16 years) were surveyed using standardized questionnaires in a tertiary epilepsy center. Occurrence of PIA was retrospectively assessed over the preceding 12 months and defined by a score of ≥ 2 on the Overt aggression scale modified (OAS-M). Anxiety and depression were measured with the Hospital anxiety and depression scale (HADS-A, HADS-D) and the Neurological disorders depression inventory in epilepsy (NDDI-E).
resultsA total of 201 patients were included (57% male; median age 47 years; 76% focal epilepsy, 14% idiopathic generalized epilepsy (IGE), 10% unclassified). Twenty-four patients (12%) reported clinically relevant PIA. Patients with PIA had lower QoL (QOLIE-10 median 40 vs. 37, p = 0.031) and more frequent clinically relevant anxiety (HADS-A ≥ 8: 58% vs. 30%, p = 0.019). Depressive symptoms were more common in PIA (NDDI-E ≥ 16: 21% vs. 10%) without statistical significance (p = 0.309). IGE (OR 3.13, 95% CI 1.06-8.98) and anxiety (OR 2.51, 95% CI 1.02-6.26) were independently associated with PIA. There were no associations with antiseizure medications or their dosage. Ten patients reported adverse consequences of PIA, most commonly shame and fear.
conclusionAlmost one in eight patients experienced PIA. It was associated with reduced QoL and increased anxiety, highlighting the psychosocial burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.